These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7182456)

  • 21. The effect of pH and concentration on alpha-methyldopa absorption in man.
    Merfeld AE; Mlodozeniec AR; Cortese MA; Rhodes JB; Dressman JB; Admidon GL
    J Pharm Pharmacol; 1986 Nov; 38(11):815-22. PubMed ID: 2879011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of methyldopa in healthy man.
    Stenbaek O; Myhre E; Rugstad HE; Arnold E; Hansen T
    Eur J Clin Pharmacol; 1977 Oct; 12(2):117-23. PubMed ID: 923625
    [No Abstract]   [Full Text] [Related]  

  • 23. Carnitine and glucuronic acid conjugates of pivalic acid.
    Vickers S; Duncan CA; White SD; Ramjit HG; Smith JL; Walker RW; Flynn H; Arison BH
    Xenobiotica; 1985 Jun; 15(6):453-8. PubMed ID: 4036169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA; Stoeckel K
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of methyldopa absorption, metabolism, and blood pressure control caused by ferrous sulfate and ferrous gluconate.
    Campbell N; Paddock V; Sundaram R
    Clin Pharmacol Ther; 1988 Apr; 43(4):381-6. PubMed ID: 3356082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of beta-methyldigoxin in healthy humans II: Oral studies and bioavailability.
    Hinderling PH; Garrett ER; Wester RC
    J Pharm Sci; 1977 Mar; 66(3):314-25. PubMed ID: 845795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New centrally acting antihypertensive drugs related to methyldopa and clonidine.
    Sweet CS
    Hypertension; 1984; 6(5 Pt 2):II51-6. PubMed ID: 6094350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of oral sustained release clonidine in humans.
    MacGregor TR; Relihan GL; Keirns JJ
    Arzneimittelforschung; 1985; 35(1A):440-6. PubMed ID: 4039184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration.
    Bullingham R; Monroe S; Nicholls A; Hale M
    J Clin Pharmacol; 1996 Apr; 36(4):315-24. PubMed ID: 8728345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-Acetyl, 4-O-methyldopa, a major metabolite of L-4-O-methyldopa in man and rat.
    Mathieu P; Greffe J; Deruaz D; Guilluy R; Gjessing L
    Biochem Pharmacol; 1976 Mar; 25(5):497-500. PubMed ID: 942485
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolism of L-alpha-methyldopa in cultured human intestinal epithelial (Caco-2) cell monolayers. Comparison with metabolism in vivo.
    Chikhale PJ; Borchardt RT
    Drug Metab Dispos; 1994; 22(4):592-600. PubMed ID: 7956735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
    Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of action of methyldopa in the rat. Role of 3-O-methylated metabolites.
    Zavisca FG; Breau AP; Wurtman RJ
    Circ Res; 1979 Nov; 45(5):684-90. PubMed ID: 487531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic disposition and cardiovascular effects of methyldopate in unanesthetized rhesus monkeys.
    Walson PD; Marshall KS; Forsyth RP; Rapoport R; Melmon KL; Castagnoli N
    J Pharmacol Exp Ther; 1975 Oct; 195(1):151-8. PubMed ID: 810574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First-pass metabolism of nortriptyline in man.
    Gram LF; Overo KF
    Clin Pharmacol Ther; 1975 Sep; 18(3):305-14. PubMed ID: 1164819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics of intravenous and oral pentoxifylline in healthy subjects.
    Beermann B; Ings R; Månsby J; Chamberlain J; McDonald A
    Clin Pharmacol Ther; 1985 Jan; 37(1):25-8. PubMed ID: 3965236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isosorbide 5-mononitrate and isosorbide 2-mononitrate kinetics after intravenous and oral dosing.
    Straehl P; Galeazzi RL; Soliva M
    Clin Pharmacol Ther; 1984 Oct; 36(4):485-92. PubMed ID: 6478734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of prenalterol in healthy subjects and patients with congestive heart failure.
    Rönn O
    Acta Med Scand Suppl; 1982; 659():89-98. PubMed ID: 6127901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of triamterene after i.v. administration to man: determination of bioavailability.
    Gilfrich HJ; Kremer G; Möhrke W; Mutschler E; Völger KD
    Eur J Clin Pharmacol; 1983; 25(2):237-41. PubMed ID: 6628507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of first-pass metabolism of ethanol at blood concentrations in the social drinking range.
    Wagner JG
    Life Sci; 1986 Aug; 39(5):407-14. PubMed ID: 3736333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.